# 72516-011-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Oryza Pharmaceuticals Inc. — FDA drug shortage duration tracker

For 72516-011-01 · Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet · Oryza Pharmaceuticals Inc., package ndc is 72516-011-01; generic name is Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet; manufacturer is Oryza Pharmaceuticals Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.

- **Package NDC:** 72516-011-01 _(verified: appears in the quote below)_
- **Generic name:** Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet _(verified: appears in the quote below)_
- **Manufacturer:** Oryza Pharmaceuticals Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Estimated availability April 2027 _(verified: appears in the quote below)_
- **Initial posting date:** 10/12/2022 _(verified: appears in the quote below)_
- **Last update date:** 08/04/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1420 _(our reading, not quoted from the source)_
- **Reason for shortage:** Shortage of an active ingredient _(verified: appears in its own passage below)_
- **Dosage form:** Tablet _(verified: appears in its own passage below)_
- **Therapeutic category:** Psychiatry _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "10/12/2022", "package_ndc": "72516-011-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "855-257-0292", "availability": "Unavailable", "related_info": "Estimated availability April 2027"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"

### Status

> "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"

### Last update date

> "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"

### Reason for shortage

> "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"

### Dosage form

> "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"

### Therapeutic category

> "update_date": "08/04/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)", "company_name": "Oryza Pharmaceuticals Inc.", "shortage_reason": "Shortage of an active ingredient", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).